Hisse Senetlerindeki Sıralama
#6594
GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to... GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) treatments, specifically targeting patients with treatment-resistant depression (TRD). Its most advanced program is GH001, an inhalable 5-MeO-DMT product candidate that has successfully completed two Phase 1 clinical trials and a subsequent Phase 1/2 clinical trial in TRD patients. Additionally, GH Research is developing GH002, an injectable 5-MeO-DMT candidate, and GH003, an intranasal 5-MeO-DMT candidate. Both GH002 and GH003 are currently in preclinical development, with a focus on their potential applications in various psychiatric and neurological disorders. Founded in 2018, GH Research PLC is headquartered in Dublin, Ireland.
Ticaret GH Research PLC (GHRS)
B piyasa değeri ile GHRS fiyatı
Piyasa Değeri GH Research PLC(GHRS)
Piyasa Değeri: $1.96B
August 2026 itibarıyla GH Research PLC şirketinin piyasa değeri $1.96B. Bu, verilerimize göre GH Research PLC şirketini dünyanın en değerli 6594th. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
GH Research PLC piyasa değeri geçmişi (2021 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında GHRS
| GHRS’in Fiyatı |
|
B Varlığı |
B’nin Piyasa Değeri |
Sonuçlar |
|
|
|
|
$5.532T
|
+282,710.35%
|
|
|
|
|
$4.608T
|
+235,498.50%
|
|
|
|
|
$4.096T
|
+209,294.51%
|
|
|
|
|
$3.748T
|
+191,543.07%
|
|
|
|
|
$2.761T
|
+141,077.90%
|
